APA

Walmsley S. L., Katlama C., Lazzarin A., Arestéh K., Pierone G., Blick G., Johnson M., Meier U., MacGregor T. R. & Leith J. G. (20080512). Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51). : Journal of acquired immune deficiency syndromes (1999).

Chicago

Walmsley Sharon L, Katlama Christine, Lazzarin Adriano, Arestéh Keikawus, Pierone Gerald, Blick Gary, Johnson Margaret, Meier Ulrich, MacGregor Thomas R and Leith Johnathan G. 20080512. Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51). : Journal of acquired immune deficiency syndromes (1999).

Harvard

Walmsley S. L., Katlama C., Lazzarin A., Arestéh K., Pierone G., Blick G., Johnson M., Meier U., MacGregor T. R. and Leith J. G. (20080512). Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51). : Journal of acquired immune deficiency syndromes (1999).

MLA

Walmsley Sharon L, Katlama Christine, Lazzarin Adriano, Arestéh Keikawus, Pierone Gerald, Blick Gary, Johnson Margaret, Meier Ulrich, MacGregor Thomas R and Leith Johnathan G. Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51). : Journal of acquired immune deficiency syndromes (1999). 20080512.